✦ LIBER ✦

Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: 10-Year Follow-Up

✍ Scribed by Tae-Won Kim; Je-Hwan Lee; Jung-Hee Lee; Jin-Hee Ahn; Yoon-Koo Kang; Kyoo-Hyung Lee; Chang-Sik Yu; Jong-Hoon Kim; Seung-Do Ahn; Woo-Kun Kim; Jin-Cheon Kim; Jung-Shin Lee

Book ID: 118455220
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 367 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.07.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognosis of stage III breast cancer

The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen: Eight year follow-up results of a randomized trial

✍ Tiina Saarto; Carl Blomqvist; Kari Tiusanen; Pentti Gröhn; Pentti Rissanen; Inke 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Phase I/II Trial of the Addition of Erlo

Phase I/II Trial of the Addition of Erlotinib to Pre- and Postoperative Chemotherapy/Hyperfractionated Radiotherapy, and as Maintenance, for Resectable Mediastinoscopy-defined Stage III Non–small-cell Lung Cancer (NSCLC): Report on the Phase II Component

✍ G.M. Videtic; T. Rice; S. Murthy; D. Mason; P. Mazzone; N. Pennell; M. Shapiro; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views